Chongqing Zhifei Bio Products (300122) — Cash Flow-to-Debt Ratio
Chongqing Zhifei Bio Products (300122) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥1.42 Billion could theoretically repay 0% of its total liabilities (CN¥16.79 Billion) in one year. See Chongqing Zhifei Bio Products free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chongqing Zhifei Bio Products Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Chongqing Zhifei Bio Products across 19 annual periods. Also explore Chongqing Zhifei Bio Products net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Chongqing Zhifei Bio Products (2007–2025)
Year-by-year debt coverage analysis for Chongqing Zhifei Bio Products. For market capitalisation and broader financial context, see 300122 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥5.17 Billion | CN¥15.61 Billion | ▲ +243.0% |
| 2024 | -0.23x | CN¥-4.41 Billion | CN¥19.08 Billion | ▼ -148.2% |
| 2023 | 0.48x | CN¥9.00 Billion | CN¥18.73 Billion | ▲ +232.5% |
| 2022 | 0.14x | CN¥1.99 Billion | CN¥13.77 Billion | ▼ -79.0% |
| 2021 | 0.69x | CN¥8.51 Billion | CN¥12.39 Billion | ▲ +36.9% |
| 2020 | 0.50x | CN¥3.50 Billion | CN¥6.97 Billion | ▲ +90.6% |
| 2019 | 0.26x | CN¥1.37 Billion | CN¥5.20 Billion | ▲ +18.1% |
| 2018 | 0.22x | CN¥585.59 Million | CN¥2.63 Billion | ▲ +27.8% |
| 2017 | 0.17x | CN¥203.61 Million | CN¥1.17 Billion | ▼ -63.5% |
| 2016 | 0.48x | CN¥89.95 Million | CN¥188.21 Million | ▼ -54.6% |
| 2015 | 1.05x | CN¥223.45 Million | CN¥212.40 Million | ▲ +67.3% |
| 2014 | 0.63x | CN¥161.39 Million | CN¥256.72 Million | ▼ -43.7% |
| 2013 | 1.12x | CN¥221.58 Million | CN¥198.61 Million | ▲ +29.0% |
| 2012 | 0.86x | CN¥112.89 Million | CN¥130.53 Million | ▼ -42.8% |
| 2011 | 1.51x | CN¥221.25 Million | CN¥146.22 Million | ▲ +88.7% |
| 2010 | 0.80x | CN¥54.19 Million | CN¥67.59 Million | ▼ -74.7% |
| 2009 | 3.18x | CN¥210.61 Million | CN¥66.33 Million | ▲ +175.9% |
| 2008 | 1.15x | CN¥141.58 Million | CN¥123.05 Million | ▲ +48.7% |
| 2007 | 0.77x | CN¥111.66 Million | CN¥144.27 Million | — |